featured
Autologous HSCT and the Development of Second Primary Malignancies in Multiple Myeloma Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Autologous Hematopoietic Stem Cell Transplant on the Development of Second Primary Malignancies in Multiple Myeloma Patients
Blood Cancer J 2021 Jan 07;11(1)5, AS Rosenberg, A Brunson, J Tuscano, BA Jonas, R Hoeg, T Wun, THM KeeganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.